Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy

NCT ID: NCT01938313

Last Updated: 2017-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of reducing the surgical stress response and obtaining optimal recovery after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is strong evidence of the usefulness of the ERAS programs in patients undergoing colorectal surgery in terms of significantly reduced postoperative complications and shorter length of hospital stay, compared to the patients of conventional treatment.

However, few studies exist about the implication of ERAS programs in the laparoscopic gastrectomy.

The aim of this study was to compare the recovery rate, morbidity, and quality of life in the patients undergoing laparoscopic gastrectomy for gastric cancer, receiving either ERAS protocol or conventional postoperative cares.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ERAS perioperative cares

Patients planned to undergoing laparoscopic gastrectomy, following the ERAS protocols.

Group Type ACTIVE_COMPARATOR

ERAS perioperative cares

Intervention Type PROCEDURE

1. Patient's preoperative counseling \& education before surgery
2. No Bowel preparation
3. Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Fluid restriction \& Management by pulse contour analysis or transesophageal doppler
5. Early mobilization
6. Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD))
7. Epidural patient controlled analgesics (no opioids analgesics)
8. Postoperative Nausea Active Control
9. Thromboembolism prophylaxis by low molecular weighted heparin (LMWH)
10. Perioperative High content Oxygen therapy
11. No drain insertion
12. No Levin tube
13. Patients will be discharged at POD#4 if there's no problem.

Conventional perioperative cares

Patents will be managed by our hospital's critical pathways.

Group Type ACTIVE_COMPARATOR

Conventional perioperative cares

Intervention Type PROCEDURE

1. No Patient's preoperative counseling \& education before surgery
2. Bowel preparation
3. No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Conventional Fluid Management by clinical signs (Urine output, heart rate etc.)
5. Conventional Mobilization
6. Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD)
7. IV PCA
8. Postoperative Nausea Control if needed
9. No Thromboembolism prophylaxis
10. No or Low Content Oxygen therapy
11. Routine drain insertion
12. Levin tube insertion if needed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ERAS perioperative cares

1. Patient's preoperative counseling \& education before surgery
2. No Bowel preparation
3. Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Fluid restriction \& Management by pulse contour analysis or transesophageal doppler
5. Early mobilization
6. Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD))
7. Epidural patient controlled analgesics (no opioids analgesics)
8. Postoperative Nausea Active Control
9. Thromboembolism prophylaxis by low molecular weighted heparin (LMWH)
10. Perioperative High content Oxygen therapy
11. No drain insertion
12. No Levin tube
13. Patients will be discharged at POD#4 if there's no problem.

Intervention Type PROCEDURE

Conventional perioperative cares

1. No Patient's preoperative counseling \& education before surgery
2. Bowel preparation
3. No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Conventional Fluid Management by clinical signs (Urine output, heart rate etc.)
5. Conventional Mobilization
6. Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD)
7. IV PCA
8. Postoperative Nausea Control if needed
9. No Thromboembolism prophylaxis
10. No or Low Content Oxygen therapy
11. Routine drain insertion
12. Levin tube insertion if needed

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective surgery
* American Society of Anesthesiologists (ASA) scores \< 3
* 20 \< Age \< 80
* Gastric cancer, adenocarcinoma, possible to perform laparoscopic distal gastrectomy
* Informed consent
* No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer or other type of cancer.
* No systemic inflammatory disease

Exclusion Criteria

* Emergency operation
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Bundang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hyung-Ho Kim

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hyung-Ho Kim, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Surgery, SNUBH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Bundang Hospital

Seongnam, Geynggi, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

References

Explore related publications, articles, or registry entries linked to this study.

Kang SH, Lee Y, Min SH, Park YS, Ahn SH, Park DJ, Kim HH. Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Prospective, Randomized, Clinical Trial. Ann Surg Oncol. 2018 Oct;25(11):3231-3238. doi: 10.1245/s10434-018-6625-0. Epub 2018 Jul 26.

Reference Type DERIVED
PMID: 30051365 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SNUBH-ERAS-GC-PII

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.